First-line lenvatinib plus pembrolizumab plus chemotherapy versus chemotherapy in advanced/metastatic gastroesophageal adenocarcinoma (LEAP-015): Safety run-in results.

Authors :: Yanez, Patricio Eduardo
Ben-Aharon, Irit
Rojas, Carlos
Acosta Eyzaguirre, Daniel
Hubert, Ayala
Araya, Hernan
Cohen, Deirdre Jill
Bai, Li-Yuan
Ghiringhelli, François
Wyrwicz, Lucjan
Janjigian, Yelena Y.
Tabernero, Josep
Van Cutsem, Eric
Qin, Shukui
Xu, Jianming
Wang, Anran
Miller, Mary Gwen
Shih, Chie-Schin
Bhagia, Pooja
Shitara, Kohei
Source :: Journal of Clinical Oncology; 2/1/2023 Supplement 1, Vol. 41, p411-411, 1p
Publication Year :: 2023

Full Text Access

Tools